Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation

Translational Neurodegeneration

Volumn 1, Issue , 2012, Pages

  Huang, Yue ^a   Chegini, Fariba ^b   Chua, Germaine ^a   Murphy, Karen ^a   Gai, Weiping ^b   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Synuclein; Macroautophagy; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; BECLIN 1;

ADULT; AGED; ALPHA SYNUCLEIN GENE; ANTERIOR CINGULATE; ARTICLE; BECLIN 1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LOCATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LC3 GENE; LEWY BODY; MACROAUTOPHAGY; MALE; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; WESTERN BLOTTING;

EID: 84862807906     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-1-2     Document Type: Article

References (39)

1. Polymeropoulos MH, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276(5321):2045-7. 10.1126/science.276.5321.2045, 9197268.
2. Kruger R, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998, 18(2):106-8. 10.1038/ng0298-106, 9462735.
3. Zarranz JJ, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004, 55(2):164-73. 10.1002/ana.10795, 14755719.
4. Singleton AB, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302(5646):841. 10.1126/science.1090278, 14593171.
5. Huang Y, et al. Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev 2004, 46(1):44-70.
6. Shin CW, et al. Two Parkinson's disease patients with alpha-synuclein gene duplication and rapid cognitive decline. Mov Disord 2010, 25(7):957-9. 10.1002/mds.23043, 20222138.
7. Braak H, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24(2):197-211. 10.1016/S0197-4580(02)00065-9, 12498954.
8. Halliday G, et al. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008, 115(4):409-15. 10.1007/s00401-008-0344-8, 18231798.
9. McLean PJ, Kawamata H, Hyman BT. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 2001, 104(3):901-12. 10.1016/S0306-4522(01)00113-0, 11440819.
10. Meredith GE, et al. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 2002, 956(1):156-65. 10.1016/S0006-8993(02)03514-X, 12426058.
11. Cuervo AM, et al. Impaired degradation of mutant alpha-synuclein by chaperone mediated autophagy. Science 2004, 305(5688):1292-5. 10.1126/science.1101738, 15333840.
12. Wilson CA, et al. Degradative organelles containing mislocalized alpha-and beta synuclein proliferate in presenilin-1 null neurons. J Cell Biol 2004, 165(3):335-46. 10.1083/jcb.200403061, 2172178, 15123735.
13. Maiuri MC, Criollo A, Kroemer G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J 2010, 29(3):515-6. 10.1038/emboj.2009.377, 2830702, 20125189.
14. Ma JF, et al. Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease. Neuropathol Appl Neurobiol 2010, 36(4):312-9. 10.1111/j.1365-2990.2010.01067.x, 20102518.
15. Crews L, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 2010, 5(2):e9313. 10.1371/journal.pone.0009313, 2824828, 20174468.
16. Choubey V, et al. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem 2011, 286(12):10814-24. 10.1074/jbc.M110.132514, 21252228.
17. Chew KC, et al. Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T {alpha}-Synuclein: IMPLICATIONS FOR NEURONAL CELL DEATH IN PARKINSON DISEASE. J Biol Chem 2011, 286(38):33380-9. 10.1074/jbc.M111.268409, 21795716.
18. Gai WP, et al. In situ and in vitro study of colocalization and segregation of alpha synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 2000, 166(2):324-33. 10.1006/exnr.2000.7527, 11085897.
19. Spira PJ, et al. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 2001, 49(3):313-9. 10.1002/ana.67, 11261505.
20. Kabeya Y, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000, 19(21):5720-8. 10.1093/emboj/19.21.5720, 305793, 11060023.
21. Russo R, et al. Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo. Cell Death Dis 2011, 2:e144. 10.1038/cddis.2011.29, 3122060, 21490676.
22. Markopoulou K, et al. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease. Acta Neuropathol 2008, 116(1):25-35. 10.1007/s00401-008-0372-4, 2728685, 18389263.
23. Giasson BI, et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 2002, 34(4):521-33. 10.1016/S0896-6273(02)00682-7, 12062037.
24. Stefanis L, et al. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001, 21(24):9549-60.
25. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998, 4(11):1318-20. 10.1038/3311, 9809558.
26. Webb JL, et al. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003, 278(27):25009-13. 10.1074/jbc.M300227200, 12719433.
27. Vogiatzi T, et al. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008, 283(35):23542-56. 10.1074/jbc.M801992200, 2527094, 18566453.
28. Yang F, et al. Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein. Neurosci Lett 2009, 454(3):203-8. 10.1016/j.neulet.2009.03.027, 19429084.
29. Prigione A, et al. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease. Neurosci Lett 2010, 477(1):6-10. 10.1016/j.neulet.2010.04.022, 20399833.
30. Su M, et al. HDAC6 regulates aggresome-autophagy degradation pathway of alpha synuclein in response to MPP+-induced stress. J Neurochem 2011, 117(1):112-20. 10.1111/j.1471-4159.2011.07180.x, 21235576.
31. Xilouri M, et al. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 2009, 4(5):e5515. 10.1371/journal.pone.0005515, 2677735, 19436756.
32. Martinez-Vicente M, et al. Dopamine-modified alpha-synuclein blocks chaperone mediated autophagy. J Clin Invest 2008, 118(2):777-88. 2157565, 18172548.
33. Sarkar S, et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 2007, 282(8):5641-52.
34. Winslow AR, et al. alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 2010, 190(6):1023-37. 10.1083/jcb.201003122, 3101586, 20855506.
35. Tanji K, et al. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis 2011, 43(3):690-7. 10.1016/j.nbd.2011.05.022, 21684337.
36. Van Humbeeck C, et al. Parkin interacts with Ambra1 to induce mitophagy. J Neurosci 2011, 31(28):10249-61. 10.1523/JNEUROSCI.1917-11.2011, 21753002.
37. Shi G, et al. Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Hum Mol Genet 2011, 20(10):1966-74. 10.1093/hmg/ddr077, 21355049.
38. Loeb V, et al. The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition. J Biol Chem 2010, 285(10):7334-43. 10.1074/jbc.M109.061051, 2844181, 20053987.
39. Esteves AR, et al. Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology. Neurobiol Dis 2010, 37(3):723-30. 10.1016/j.nbd.2009.12.011, 20034566.